These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Kallman's syndrome--hypogonadism and anosmia]. Pulli K; Pelkonen R Duodecim; 1975; 91(10):649-56. PubMed ID: 1080706 [No Abstract] [Full Text] [Related]
7. [Multiple nodular heterotopias and Kallman's syndrome]. Falero MP; Verdú A; Aragonés A Rev Neurol; 1998 Dec; 27(160):1067-8. PubMed ID: 9951039 [No Abstract] [Full Text] [Related]
8. Alopecia-anosmia-deafness-hypogonadism syndrome revisited: report of a new case. Johnston K; Golabi M; Hall B; Ito M; Grix A Am J Med Genet; 1987 Apr; 26(4):925-7. PubMed ID: 3591836 [TBL] [Abstract][Full Text] [Related]
9. Leydig cell responsiveness with germinal cell resistance to gonadotropin therapy in Kallman's syndrome. Check JH; Caro JF; Criden L; Meltz R; Brownstein K Am J Med; 1979 Sep; 67(3):495-7. PubMed ID: 474595 [No Abstract] [Full Text] [Related]
10. Plasma steroid concentrations in patients with hypopituitarism and Kallman's syndrome: effects of testosterone replacement therapy. Sagel J; Levine JH; Mathur RS; Rosebrock G; Gonzalez J; de Villier C; Nair RM Clin Endocrinol (Oxf); 1982 Sep; 17(3):223-31. PubMed ID: 6299618 [No Abstract] [Full Text] [Related]